EMG-Controlled Device for Stroke Rehabilitation
Trial Summary
The trial does not specify if you need to stop taking your current medications, but it excludes those currently taking medications that lower the threshold for seizures.
Research shows that using surface electromyography (EMG) to monitor muscle activity can help track recovery and improve rehabilitation for stroke patients. EMG feedback has been shown to enhance control and movement in stroke-affected limbs, suggesting that EMG-controlled devices like MARK could be effective in stroke rehabilitation.
12345Research on similar technologies like surface electromyography (sEMG) and MIRA has shown that they are generally safe for use in humans, with no adverse events reported in studies. These technologies are non-invasive and have been used comfortably in clinical settings to monitor muscle activity and aid rehabilitation.
12678The EMG-controlled device for stroke rehabilitation is unique because it uses electromyography (EMG) signals, which are the electrical signals from muscle contractions, to control rehabilitation devices. This allows for personalized and real-time feedback, enabling stroke patients to engage in rehabilitation exercises at home without needing a therapist present, which is different from traditional rehabilitation methods that often require in-person supervision.
19101112Eligibility Criteria
This trial is for veterans over 18 who've had an ischemic stroke within the last 6 months, can understand English, and follow directions. They should be medically stable with a certain level of muscle stiffness in their arm but able to move it enough to wear a device. They must not have severe arm contractures, involuntary movements, or conditions that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive acute rehabilitation with an EMG controlled device for stroke survivors with severe arm deficit
Follow-up
Participants are monitored for changes in arm function and impairment after treatment